320 related articles for article (PubMed ID: 31296080)
1. Guideline-Based Referral for Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Is Associated With Excellent Clinical Outcomes.
Kimmelstiel C; Zisa DC; Kuttab JS; Wells S; Udelson JE; Wessler BS; Rastegar H; Kapur NK; Weintraub AR; Maron BJ; Maron MS; Rowin EJ
Circ Cardiovasc Interv; 2019 Jul; 12(7):e007673. PubMed ID: 31296080
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of Alcohol Septal Ablation in Younger Patients With Obstructive Hypertrophic Cardiomyopathy.
Liebregts M; Faber L; Jensen MK; Vriesendorp PA; Januska J; Krejci J; Hansen PR; Seggewiss H; Horstkotte D; Adlova R; Bundgaard H; Ten Berg JM; Veselka J
JACC Cardiovasc Interv; 2017 Jun; 10(11):1134-1143. PubMed ID: 28595881
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy in the Young and the Elderly.
Liebregts M; Steggerda RC; Vriesendorp PA; van Velzen H; Schinkel AF; Willems R; van Cleemput J; van den Berg MP; Michels M; ten Berg JM
JACC Cardiovasc Interv; 2016 Mar; 9(5):463-9. PubMed ID: 26965935
[TBL] [Abstract][Full Text] [Related]
4. The long-term outcomes of transcoronary ablation of septal hypertrophy compared to surgical myectomy in patients with symptomatic hypertrophic obstructive cardiomyopathy.
Samardhi H; Walters DL; Raffel C; Rateesh S; Harley C; Burstow D; Pohlner P; Aroney C
Catheter Cardiovasc Interv; 2014 Feb; 83(2):270-7. PubMed ID: 23873660
[TBL] [Abstract][Full Text] [Related]
5. A meta analysis of current status of alcohol septal ablation and surgical myectomy for obstructive hypertrophic cardiomyopathy.
Singh K; Qutub M; Carson K; Hibbert B; Glover C
Catheter Cardiovasc Interv; 2016 Jul; 88(1):107-15. PubMed ID: 26526299
[TBL] [Abstract][Full Text] [Related]
6. Does ablation of atrial fibrillation at the time of septal myectomy improve survival of patients with obstructive hypertrophic cardiomyopathy?
Cui H; Schaff HV; Dearani JA; Lahr BD; Viehman JK; Geske JB; Nishimura RA; Ommen SR
J Thorac Cardiovasc Surg; 2021 Mar; 161(3):997-1006.e3. PubMed ID: 32977972
[TBL] [Abstract][Full Text] [Related]
7. Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experience.
Steggerda RC; Damman K; Balt JC; Liebregts M; ten Berg JM; van den Berg MP
JACC Cardiovasc Interv; 2014 Nov; 7(11):1227-34. PubMed ID: 25326737
[TBL] [Abstract][Full Text] [Related]
8. Influence of Septal Thickness on the Clinical Outcome After Alcohol Septal Alation in Hypertrophic Cardiomyopathy.
Jensen MK; Jacobsson L; Almaas V; van Buuren F; Hansen PR; Hansen TF; Aakhus S; Eriksson MJ; Bundgaard H; Faber L
Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27217377
[TBL] [Abstract][Full Text] [Related]
9. Hospital Volume Outcomes After Septal Myectomy and Alcohol Septal Ablation for Treatment of Obstructive Hypertrophic Cardiomyopathy: US Nationwide Inpatient Database, 2003-2011.
Kim LK; Swaminathan RV; Looser P; Minutello RM; Wong SC; Bergman G; Naidu SS; Gade CL; Charitakis K; Singh HS; Feldman DN
JAMA Cardiol; 2016 Jun; 1(3):324-32. PubMed ID: 27438114
[TBL] [Abstract][Full Text] [Related]
10. Surgical septal myectomy or alcohol septal ablation: which approach offers better outcomes for patients with hypertrophic obstructive cardiomyopathy?
Poon SS; Field M; Gupta D; Cameron D
Interact Cardiovasc Thorac Surg; 2017 Jun; 24(6):951-961. PubMed ID: 28329292
[TBL] [Abstract][Full Text] [Related]
11. Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long-Term Follow-Up Study Based on the Euro-Alcohol Septal Ablation Registry.
Veselka J; Faber L; Liebregts M; Cooper R; Januska J; Krejci J; Bartel T; Dabrowski M; Hansen PR; Almaas VM; Seggewiss H; Horstkotte D; Adlova R; Bundgaard H; Ten Berg J; Stables RH; Jensen MK
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28512112
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy.
Sedehi D; Finocchiaro G; Tibayan Y; Chi J; Pavlovic A; Kim YM; Tibayan FA; Reitz BA; Robbins RC; Woo J; Ha R; Lee DP; Ashley EA
J Cardiol; 2015 Jul; 66(1):57-62. PubMed ID: 25238885
[TBL] [Abstract][Full Text] [Related]
13. Differences in Short-Term Outcomes and Hospital-Based Resource Utilization Between Septal Reduction Strategies for Hypertrophic Obstructive Cardiomyopathy.
Yandrapalli S; Harikrishnan P; Andries G; Aronow WS; Panza JA; Naidu SS
J Invasive Cardiol; 2022 Jan; 34(1):E8-E13. PubMed ID: 34919530
[TBL] [Abstract][Full Text] [Related]
14. A Systematic Review and Meta-Analysis of Long-Term Outcomes After Septal Reduction Therapy in Patients With Hypertrophic Cardiomyopathy.
Liebregts M; Vriesendorp PA; Mahmoodi BK; Schinkel AF; Michels M; ten Berg JM
JACC Heart Fail; 2015 Nov; 3(11):896-905. PubMed ID: 26454847
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Outcomes of Alcohol Septal Ablation or Septal Myectomy for Hypertrophic Cardiomyopathy in Patients ≤65 Years Versus >65 Years.
Lemor A; Villablanca PA; Hosseini Dehkordi SH; Mand R; Hernandez GA; Jain T; Blumer VL; Lee J; Eng M; Guerrero M; Wang DD; Palacios I; O'Neill W
Am J Cardiol; 2020 Jul; 127():128-134. PubMed ID: 32402483
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Survival After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16-Year Experience.
Fernandes V; Karimianpour A; Rier JD; Shaji S; Mullinax BJ; Wahlquist AH; Nielsen CD
J Invasive Cardiol; 2021 Oct; 33(10):E769-E776. PubMed ID: 34559674
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and outcomes of alcohol septal ablation in the era of transcatheter valve interventions.
Engel Gonzalez P; Gregerson S; Mahmood S; Brooks C; Villablanca PA; Frisoli TM; Lee J; Wyman JF; Wang DD; O'Neill WW; O'Neill BP
Catheter Cardiovasc Interv; 2024 May; 103(6):1023-1034. PubMed ID: 38639143
[TBL] [Abstract][Full Text] [Related]
18. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
Alam M; Dokainish H; Lakkis N
J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
[TBL] [Abstract][Full Text] [Related]
19. Predictors of long-term outcome after septal myectomy in symptomatic hypertrophic obstructive cardiomyopathy patients with previous alcohol septal ablation and residual obstruction.
Zhu C; Tang B; Cui H; Wang S; Xiao M; Chen Z; Meng Y; Zhao S; Song Y; Yu Q; Wang S
J Card Surg; 2019 Jul; 34(7):533-540. PubMed ID: 31111576
[TBL] [Abstract][Full Text] [Related]
20. Impact of type 2 diabetes mellitus on mid-term mortality for hypertrophic cardiomyopathy patients who underwent septal myectomy.
Wang S; Cui H; Ji K; Song C; Ren C; Guo H; Zhu C; Wang S; Lai Y
Cardiovasc Diabetol; 2020 May; 19(1):64. PubMed ID: 32404127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
